Skip to content
Today: Thursday, December 11 2025
probingedge
Probing Edge
probingedge
Probing Edge
  • Home
  • About Us
  • Privacy Policy
  • Contact us
  • News
    • Global Affairs
    • Entertainment
    • Business
  • Healthcare
  • Blogs
    • Food and Beverages
    • Technology
    • Chemical
    • Consumer Goods
    • Life Sciences
    • Electronics & Semiconductors
    • Telecommunication

What are You Looking For?

Trending News

Why Choose Sovereign AI Strategies for Data Localization?

Why Choose Sovereign AI Strategies for Data Localization?

on December 11, 2025December 11, 2025
Posted by Preety Shaha
Minors’ Social Media Regulation Sparks Debate Across Australia

Minors’ Social Media Regulation Sparks Debate Across Australia

on December 11, 2025December 11, 2025
Posted by Druti Banerjee
AI & Advanced Imaging Transform Lymphedema Diagnostics

AI & Advanced Imaging Transform Lymphedema Diagnostics

on December 11, 2025December 11, 2025
Posted by Mursalin Pathan
Synopsys Chip Design Tools Demand Outpaces Competitors

Synopsys Chip Design Tools Demand Outpaces Competitors

on December 11, 2025December 11, 2025
Posted by Preety Shaha
  • Home
  • About Us
  • Privacy Policy
  • Contact us
  • News
    • Global Affairs
    • Entertainment
    • Business
  • Healthcare
  • Blogs
    • Food and Beverages
    • Technology
    • Chemical
    • Consumer Goods
    • Life Sciences
    • Electronics & Semiconductors
    • Telecommunication
© All rights reserved. Proudly powered by WordPress. Theme TruthNews designed by WPInterface.
  • Home
  • FDA

FDA

7 posts
Posted in News

FDA Approves Revumenib as Therapy for Relapsed or Refractory AML

on October 27, 2025October 27, 2025
Mursalin Pathan
Posted in News

FDA Grants Approval to BLENREP for Treating Multiple Myeloma

on October 24, 2025October 24, 2025
Mursalin Pathan
Posted in News

Zynex Receives FDA Approval for TensWave, Expands Drug-Free Pain Therapy

on October 20, 2025October 20, 2025
Mursalin Pathan
Posted in News

FDA Approves Combo Therapy to Prolong Survival in Advanced Lung Cancer

on October 7, 2025October 7, 2025
Mursalin Pathan
Posted in News

FDA Expands Evkeeza Approval to Children 1+ with Rare Cholesterol Disorder

on October 3, 2025October 3, 2025
Mursalin Pathan
Posted in News

FDA Rejects Regeneron’s Request to Expand EYLEA HD® Label

on August 26, 2025August 26, 2025
Mursalin Pathan
FDA Grants Accelerated Approval to Avutometinib–Defactinib Combo for KRAS-Mutant Ovarian Cancer
Posted in News

FDA Grants Accelerated Approval to Avutometinib–Defactinib Combo for KRAS-Mutant Ovarian Cancer

on August 21, 2025August 21, 2025
Mursalin Pathan

No widgets added yet. Add widgets on Off-canvas Drawer .

© All rights reserved. Proudly powered by WordPress. Theme TruthNews designed by WPInterface.